Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-12-001235
Filing Date
2012-04-17
Accepted
2012-04-17 17:37:16
Documents
1
Period of Report
2012-04-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT milligan-form4_04162012.html 4  
1 OWNERSHIP DOCUMENT milligan-form4_04162012.xml 4 3717
  Complete submission text file 0001387131-12-001235.txt   5413
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 516-961-1911
TherapeuticsMD, Inc. (Issuer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: UT | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address
Milligan John C.K. IV (Reporting) CIK: 0001532230 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16731 | Film No.: 12764565